nodes	percent_of_prediction	percent_of_DWPC	metapath
Proparacaine—Metoclopramide—Sunitinib—kidney cancer	0.512	0.567	CrCrCtD
Proparacaine—Procainamide—Sunitinib—kidney cancer	0.391	0.433	CrCrCtD
Proparacaine—SCN3A—Interaction between L1 and Ankyrins—L1CAM—kidney cancer	0.00385	0.0558	CbGpPWpGaD
Proparacaine—SCN3A—Interaction between L1 and Ankyrins—SPTBN4—kidney cancer	0.00385	0.0558	CbGpPWpGaD
Proparacaine—SCN2A—Interaction between L1 and Ankyrins—L1CAM—kidney cancer	0.00369	0.0536	CbGpPWpGaD
Proparacaine—SCN2A—Interaction between L1 and Ankyrins—SPTBN4—kidney cancer	0.00369	0.0536	CbGpPWpGaD
Proparacaine—SCN1A—Interaction between L1 and Ankyrins—L1CAM—kidney cancer	0.00356	0.0517	CbGpPWpGaD
Proparacaine—SCN10A—Interaction between L1 and Ankyrins—L1CAM—kidney cancer	0.00356	0.0517	CbGpPWpGaD
Proparacaine—SCN1A—Interaction between L1 and Ankyrins—SPTBN4—kidney cancer	0.00356	0.0517	CbGpPWpGaD
Proparacaine—SCN10A—Interaction between L1 and Ankyrins—SPTBN4—kidney cancer	0.00356	0.0517	CbGpPWpGaD
Proparacaine—SCN3A—L1CAM interactions—SPTBN4—kidney cancer	0.00148	0.0214	CbGpPWpGaD
Proparacaine—SCN3A—L1CAM interactions—L1CAM—kidney cancer	0.00148	0.0214	CbGpPWpGaD
Proparacaine—Keratitis—Erlotinib—kidney cancer	0.00144	0.0639	CcSEcCtD
Proparacaine—Liver disorder—Everolimus—kidney cancer	0.00142	0.063	CcSEcCtD
Proparacaine—SCN2A—L1CAM interactions—L1CAM—kidney cancer	0.00142	0.0206	CbGpPWpGaD
Proparacaine—SCN2A—L1CAM interactions—SPTBN4—kidney cancer	0.00142	0.0206	CbGpPWpGaD
Proparacaine—Liver disorder—Erlotinib—kidney cancer	0.00137	0.0608	CcSEcCtD
Proparacaine—SCN10A—L1CAM interactions—L1CAM—kidney cancer	0.00137	0.0198	CbGpPWpGaD
Proparacaine—SCN1A—L1CAM interactions—SPTBN4—kidney cancer	0.00137	0.0198	CbGpPWpGaD
Proparacaine—SCN10A—L1CAM interactions—SPTBN4—kidney cancer	0.00137	0.0198	CbGpPWpGaD
Proparacaine—SCN1A—L1CAM interactions—L1CAM—kidney cancer	0.00137	0.0198	CbGpPWpGaD
Proparacaine—Necrosis—Dactinomycin—kidney cancer	0.000977	0.0433	CcSEcCtD
Proparacaine—Oxybuprocaine—BCHE—kidney cancer	0.000897	0.175	CrCbGaD
Proparacaine—Lacrimation increased—Sunitinib—kidney cancer	0.000879	0.0389	CcSEcCtD
Proparacaine—Keratitis—Paclitaxel—kidney cancer	0.000839	0.0372	CcSEcCtD
Proparacaine—Chloroprocaine—BCHE—kidney cancer	0.000834	0.162	CrCbGaD
Proparacaine—Procaine—BCHE—kidney cancer	0.000795	0.155	CrCbGaD
Proparacaine—Cinchocaine—BCHE—kidney cancer	0.000795	0.155	CrCbGaD
Proparacaine—SCN3A—Axon guidance—UNC5C—kidney cancer	0.000736	0.0107	CbGpPWpGaD
Proparacaine—SCN2A—Axon guidance—UNC5C—kidney cancer	0.000707	0.0103	CbGpPWpGaD
Proparacaine—Procainamide—ACHE—kidney cancer	0.0007	0.136	CrCbGaD
Proparacaine—Necrosis—Paclitaxel—kidney cancer	0.000693	0.0307	CcSEcCtD
Proparacaine—Keratitis—Capecitabine—kidney cancer	0.000689	0.0305	CcSEcCtD
Proparacaine—SCN10A—Axon guidance—UNC5C—kidney cancer	0.000682	0.00989	CbGpPWpGaD
Proparacaine—SCN1A—Axon guidance—UNC5C—kidney cancer	0.000682	0.00989	CbGpPWpGaD
Proparacaine—Haemoglobin—Pazopanib—kidney cancer	0.00062	0.0275	CcSEcCtD
Proparacaine—Haemorrhage—Pazopanib—kidney cancer	0.000617	0.0273	CcSEcCtD
Proparacaine—Lacrimation increased—Paclitaxel—kidney cancer	0.000591	0.0262	CcSEcCtD
Proparacaine—SCN3A—L1CAM interactions—PAK1—kidney cancer	0.000566	0.00821	CbGpPWpGaD
Proparacaine—SCN3A—Axon guidance—SPTBN4—kidney cancer	0.000558	0.00809	CbGpPWpGaD
Proparacaine—SCN3A—Axon guidance—L1CAM—kidney cancer	0.000558	0.00809	CbGpPWpGaD
Proparacaine—SCN2A—L1CAM interactions—PAK1—kidney cancer	0.000543	0.00789	CbGpPWpGaD
Proparacaine—SCN2A—Axon guidance—L1CAM—kidney cancer	0.000536	0.00778	CbGpPWpGaD
Proparacaine—SCN2A—Axon guidance—SPTBN4—kidney cancer	0.000536	0.00778	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—UNC5C—kidney cancer	0.000525	0.00762	CbGpPWpGaD
Proparacaine—SCN1A—L1CAM interactions—PAK1—kidney cancer	0.000524	0.0076	CbGpPWpGaD
Proparacaine—SCN10A—L1CAM interactions—PAK1—kidney cancer	0.000524	0.0076	CbGpPWpGaD
Proparacaine—SCN1A—Axon guidance—L1CAM—kidney cancer	0.000517	0.0075	CbGpPWpGaD
Proparacaine—SCN10A—Axon guidance—L1CAM—kidney cancer	0.000517	0.0075	CbGpPWpGaD
Proparacaine—SCN10A—Axon guidance—SPTBN4—kidney cancer	0.000517	0.0075	CbGpPWpGaD
Proparacaine—SCN1A—Axon guidance—SPTBN4—kidney cancer	0.000517	0.0075	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—UNC5C—kidney cancer	0.000505	0.00732	CbGpPWpGaD
Proparacaine—Haemoglobin—Vinblastine—kidney cancer	0.000491	0.0218	CcSEcCtD
Proparacaine—Lacrimation—Doxorubicin—kidney cancer	0.00049	0.0217	CcSEcCtD
Proparacaine—Haemoglobin—Everolimus—kidney cancer	0.00049	0.0217	CcSEcCtD
Proparacaine—Haemorrhage—Vinblastine—kidney cancer	0.000489	0.0217	CcSEcCtD
Proparacaine—Haemorrhage—Everolimus—kidney cancer	0.000487	0.0216	CcSEcCtD
Proparacaine—SCN1A—Developmental Biology—UNC5C—kidney cancer	0.000487	0.00706	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—UNC5C—kidney cancer	0.000487	0.00706	CbGpPWpGaD
Proparacaine—Lacrimation increased—Capecitabine—kidney cancer	0.000485	0.0215	CcSEcCtD
Proparacaine—Haemoglobin—Erlotinib—kidney cancer	0.000472	0.0209	CcSEcCtD
Proparacaine—Haemorrhage—Erlotinib—kidney cancer	0.00047	0.0208	CcSEcCtD
Proparacaine—Amiodarone—CYP1A1—kidney cancer	0.000458	0.0892	CrCbGaD
Proparacaine—Keratitis—Doxorubicin—kidney cancer	0.000444	0.0197	CcSEcCtD
Proparacaine—Haemoglobin—Sorafenib—kidney cancer	0.000425	0.0188	CcSEcCtD
Proparacaine—Haemorrhage—Sorafenib—kidney cancer	0.000423	0.0187	CcSEcCtD
Proparacaine—Procainamide—BCHE—kidney cancer	0.000412	0.0802	CrCbGaD
Proparacaine—Haemoglobin—Sunitinib—kidney cancer	0.000409	0.0181	CcSEcCtD
Proparacaine—Haemorrhage—Sunitinib—kidney cancer	0.000407	0.018	CcSEcCtD
Proparacaine—SCN3A—Developmental Biology—SPTBN4—kidney cancer	0.000398	0.00578	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—L1CAM—kidney cancer	0.000398	0.00578	CbGpPWpGaD
Proparacaine—Pain—Temsirolimus—kidney cancer	0.000398	0.0176	CcSEcCtD
Proparacaine—SCN2A—Developmental Biology—SPTBN4—kidney cancer	0.000382	0.00555	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—L1CAM—kidney cancer	0.000382	0.00555	CbGpPWpGaD
Proparacaine—Pain—Pazopanib—kidney cancer	0.000375	0.0166	CcSEcCtD
Proparacaine—SCN10A—Developmental Biology—SPTBN4—kidney cancer	0.000369	0.00535	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—SPTBN4—kidney cancer	0.000369	0.00535	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—L1CAM—kidney cancer	0.000369	0.00535	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—L1CAM—kidney cancer	0.000369	0.00535	CbGpPWpGaD
Proparacaine—Necrosis—Doxorubicin—kidney cancer	0.000367	0.0162	CcSEcCtD
Proparacaine—Stinging—Doxorubicin—kidney cancer	0.000355	0.0157	CcSEcCtD
Proparacaine—SCN3A—Developmental Biology—CER1—kidney cancer	0.000348	0.00505	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—CER1—kidney cancer	0.000334	0.00485	CbGpPWpGaD
Proparacaine—Haemoglobin—Gemcitabine—kidney cancer	0.000328	0.0145	CcSEcCtD
Proparacaine—Haemorrhage—Gemcitabine—kidney cancer	0.000326	0.0145	CcSEcCtD
Proparacaine—SCN10A—Developmental Biology—CER1—kidney cancer	0.000322	0.00468	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—CER1—kidney cancer	0.000322	0.00468	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—EPAS1—kidney cancer	0.000315	0.00457	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—HNF1A—kidney cancer	0.000315	0.00457	CbGpPWpGaD
Proparacaine—Lacrimation increased—Doxorubicin—kidney cancer	0.000312	0.0138	CcSEcCtD
Proparacaine—SCN2A—Developmental Biology—HNF1A—kidney cancer	0.000302	0.00439	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—EPAS1—kidney cancer	0.000302	0.00439	CbGpPWpGaD
Proparacaine—Pain—Vinblastine—kidney cancer	0.000297	0.0132	CcSEcCtD
Proparacaine—Pain—Everolimus—kidney cancer	0.000296	0.0131	CcSEcCtD
Proparacaine—SCN10A—Developmental Biology—HNF1A—kidney cancer	0.000291	0.00423	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—HNF1A—kidney cancer	0.000291	0.00423	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—EPAS1—kidney cancer	0.000291	0.00423	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—EPAS1—kidney cancer	0.000291	0.00423	CbGpPWpGaD
Proparacaine—Pain—Erlotinib—kidney cancer	0.000286	0.0126	CcSEcCtD
Proparacaine—Dermatitis contact—Doxorubicin—kidney cancer	0.000285	0.0126	CcSEcCtD
Proparacaine—Haemoglobin—Paclitaxel—kidney cancer	0.000275	0.0122	CcSEcCtD
Proparacaine—Haemorrhage—Paclitaxel—kidney cancer	0.000273	0.0121	CcSEcCtD
Proparacaine—Pain—Sorafenib—kidney cancer	0.000257	0.0114	CcSEcCtD
Proparacaine—SCN3A—Developmental Biology—HNF1B—kidney cancer	0.000256	0.00372	CbGpPWpGaD
Proparacaine—Pain—Sunitinib—kidney cancer	0.000247	0.0109	CcSEcCtD
Proparacaine—SCN2A—Developmental Biology—HNF1B—kidney cancer	0.000246	0.00358	CbGpPWpGaD
Proparacaine—Amiodarone—ABCB1—kidney cancer	0.000244	0.0474	CrCbGaD
Proparacaine—SCN10A—Developmental Biology—HNF1B—kidney cancer	0.000238	0.00345	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—HNF1B—kidney cancer	0.000238	0.00345	CbGpPWpGaD
Proparacaine—Pain—Dactinomycin—kidney cancer	0.000234	0.0104	CcSEcCtD
Proparacaine—Haemoglobin—Capecitabine—kidney cancer	0.000225	0.00999	CcSEcCtD
Proparacaine—Haemorrhage—Capecitabine—kidney cancer	0.000224	0.00994	CcSEcCtD
Proparacaine—SCN3A—Axon guidance—PAK1—kidney cancer	0.000214	0.0031	CbGpPWpGaD
Proparacaine—Pain—Vincristine—kidney cancer	0.000209	0.00926	CcSEcCtD
Proparacaine—SCN2A—Axon guidance—PAK1—kidney cancer	0.000205	0.00298	CbGpPWpGaD
Proparacaine—Pain—Gemcitabine—kidney cancer	0.000198	0.00879	CcSEcCtD
Proparacaine—SCN1A—Axon guidance—PAK1—kidney cancer	0.000198	0.00287	CbGpPWpGaD
Proparacaine—SCN10A—Axon guidance—PAK1—kidney cancer	0.000198	0.00287	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—CTNNA1—kidney cancer	0.000184	0.00267	CbGpPWpGaD
Proparacaine—SCN3A—L1CAM interactions—MAPK3—kidney cancer	0.000183	0.00266	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—CTNNA1—kidney cancer	0.000177	0.00256	CbGpPWpGaD
Proparacaine—SCN2A—L1CAM interactions—MAPK3—kidney cancer	0.000176	0.00256	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—PAX6—kidney cancer	0.000176	0.00255	CbGpPWpGaD
Proparacaine—SCN3A—L1CAM interactions—MAPK1—kidney cancer	0.000175	0.00253	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—CTNNA1—kidney cancer	0.00017	0.00247	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—CTNNA1—kidney cancer	0.00017	0.00247	CbGpPWpGaD
Proparacaine—SCN1A—L1CAM interactions—MAPK3—kidney cancer	0.00017	0.00247	CbGpPWpGaD
Proparacaine—SCN10A—L1CAM interactions—MAPK3—kidney cancer	0.00017	0.00247	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—PAX6—kidney cancer	0.000169	0.00245	CbGpPWpGaD
Proparacaine—SCN2A—L1CAM interactions—MAPK1—kidney cancer	0.000168	0.00243	CbGpPWpGaD
Proparacaine—Pain—Paclitaxel—kidney cancer	0.000166	0.00736	CcSEcCtD
Proparacaine—SCN1A—Developmental Biology—PAX6—kidney cancer	0.000163	0.00236	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—PAX6—kidney cancer	0.000163	0.00236	CbGpPWpGaD
Proparacaine—SCN10A—L1CAM interactions—MAPK1—kidney cancer	0.000162	0.00235	CbGpPWpGaD
Proparacaine—SCN1A—L1CAM interactions—MAPK1—kidney cancer	0.000162	0.00235	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—PAK1—kidney cancer	0.000153	0.00221	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—PAK1—kidney cancer	0.000147	0.00213	CbGpPWpGaD
Proparacaine—Haemoglobin—Doxorubicin—kidney cancer	0.000145	0.00644	CcSEcCtD
Proparacaine—Haemorrhage—Doxorubicin—kidney cancer	0.000145	0.0064	CcSEcCtD
Proparacaine—SCN10A—Developmental Biology—PAK1—kidney cancer	0.000141	0.00205	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—PAK1—kidney cancer	0.000141	0.00205	CbGpPWpGaD
Proparacaine—Pain—Capecitabine—kidney cancer	0.000136	0.00604	CcSEcCtD
Proparacaine—SCN3A—Axon guidance—KDR—kidney cancer	0.000133	0.00193	CbGpPWpGaD
Proparacaine—SCN3A—Axon guidance—MET—kidney cancer	0.00013	0.00189	CbGpPWpGaD
Proparacaine—SCN2A—Axon guidance—KDR—kidney cancer	0.000128	0.00185	CbGpPWpGaD
Proparacaine—SCN2A—Axon guidance—MET—kidney cancer	0.000125	0.00181	CbGpPWpGaD
Proparacaine—SCN10A—Axon guidance—KDR—kidney cancer	0.000123	0.00179	CbGpPWpGaD
Proparacaine—SCN1A—Axon guidance—KDR—kidney cancer	0.000123	0.00179	CbGpPWpGaD
Proparacaine—SCN10A—Axon guidance—MET—kidney cancer	0.000121	0.00175	CbGpPWpGaD
Proparacaine—SCN1A—Axon guidance—MET—kidney cancer	0.000121	0.00175	CbGpPWpGaD
Proparacaine—SCN3A—Axon guidance—RAF1—kidney cancer	9.62e-05	0.0014	CbGpPWpGaD
Proparacaine—SCN3A—Axon guidance—ERBB2—kidney cancer	9.51e-05	0.00138	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—KDR—kidney cancer	9.49e-05	0.00138	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—MET—kidney cancer	9.29e-05	0.00135	CbGpPWpGaD
Proparacaine—SCN2A—Axon guidance—RAF1—kidney cancer	9.24e-05	0.00134	CbGpPWpGaD
Proparacaine—SCN2A—Axon guidance—ERBB2—kidney cancer	9.14e-05	0.00133	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—KDR—kidney cancer	9.12e-05	0.00132	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—MET—kidney cancer	8.92e-05	0.0013	CbGpPWpGaD
Proparacaine—SCN1A—Axon guidance—RAF1—kidney cancer	8.91e-05	0.00129	CbGpPWpGaD
Proparacaine—SCN10A—Axon guidance—RAF1—kidney cancer	8.91e-05	0.00129	CbGpPWpGaD
Proparacaine—SCN10A—Axon guidance—ERBB2—kidney cancer	8.81e-05	0.00128	CbGpPWpGaD
Proparacaine—SCN1A—Axon guidance—ERBB2—kidney cancer	8.81e-05	0.00128	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—KDR—kidney cancer	8.79e-05	0.00128	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—KDR—kidney cancer	8.79e-05	0.00128	CbGpPWpGaD
Proparacaine—Pain—Doxorubicin—kidney cancer	8.78e-05	0.00389	CcSEcCtD
Proparacaine—SCN10A—Developmental Biology—MET—kidney cancer	8.61e-05	0.00125	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—MET—kidney cancer	8.61e-05	0.00125	CbGpPWpGaD
Proparacaine—SCN3A—Axon guidance—VEGFA—kidney cancer	7.33e-05	0.00106	CbGpPWpGaD
Proparacaine—SCN2A—Axon guidance—VEGFA—kidney cancer	7.04e-05	0.00102	CbGpPWpGaD
Proparacaine—SCN3A—Axon guidance—MAPK3—kidney cancer	6.93e-05	0.00101	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—RAF1—kidney cancer	6.86e-05	0.000996	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—RELA—kidney cancer	6.83e-05	0.000991	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—ERBB2—kidney cancer	6.79e-05	0.000985	CbGpPWpGaD
Proparacaine—SCN1A—Axon guidance—VEGFA—kidney cancer	6.79e-05	0.000985	CbGpPWpGaD
Proparacaine—SCN10A—Axon guidance—VEGFA—kidney cancer	6.79e-05	0.000985	CbGpPWpGaD
Proparacaine—SCN2A—Axon guidance—MAPK3—kidney cancer	6.66e-05	0.000967	CbGpPWpGaD
Proparacaine—SCN3A—Axon guidance—MAPK1—kidney cancer	6.6e-05	0.000957	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—RAF1—kidney cancer	6.59e-05	0.000957	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—RELA—kidney cancer	6.56e-05	0.000953	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—ERBB2—kidney cancer	6.52e-05	0.000947	CbGpPWpGaD
Proparacaine—SCN10A—Axon guidance—MAPK3—kidney cancer	6.42e-05	0.000932	CbGpPWpGaD
Proparacaine—SCN1A—Axon guidance—MAPK3—kidney cancer	6.42e-05	0.000932	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—RAF1—kidney cancer	6.36e-05	0.000923	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—RAF1—kidney cancer	6.36e-05	0.000923	CbGpPWpGaD
Proparacaine—SCN2A—Axon guidance—MAPK1—kidney cancer	6.34e-05	0.00092	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—RELA—kidney cancer	6.33e-05	0.000919	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—RELA—kidney cancer	6.33e-05	0.000919	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—ERBB2—kidney cancer	6.29e-05	0.000913	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—ERBB2—kidney cancer	6.29e-05	0.000913	CbGpPWpGaD
Proparacaine—SCN3A—Axon guidance—KRAS—kidney cancer	6.23e-05	0.000904	CbGpPWpGaD
Proparacaine—SCN1A—Axon guidance—MAPK1—kidney cancer	6.11e-05	0.000887	CbGpPWpGaD
Proparacaine—SCN10A—Axon guidance—MAPK1—kidney cancer	6.11e-05	0.000887	CbGpPWpGaD
Proparacaine—SCN2A—Axon guidance—KRAS—kidney cancer	5.99e-05	0.000869	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—CTNNB1—kidney cancer	5.94e-05	0.000862	CbGpPWpGaD
Proparacaine—SCN10A—Axon guidance—KRAS—kidney cancer	5.77e-05	0.000838	CbGpPWpGaD
Proparacaine—SCN1A—Axon guidance—KRAS—kidney cancer	5.77e-05	0.000838	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—CTNNB1—kidney cancer	5.71e-05	0.000828	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—CTNNB1—kidney cancer	5.5e-05	0.000799	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—CTNNB1—kidney cancer	5.5e-05	0.000799	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—VEGFA—kidney cancer	5.23e-05	0.000759	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—VEGFA—kidney cancer	5.02e-05	0.000729	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—MAPK3—kidney cancer	4.95e-05	0.000718	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—VEGFA—kidney cancer	4.84e-05	0.000703	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—VEGFA—kidney cancer	4.84e-05	0.000703	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—MAPK3—kidney cancer	4.75e-05	0.00069	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—MAPK1—kidney cancer	4.71e-05	0.000683	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—MAPK3—kidney cancer	4.58e-05	0.000665	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—MAPK3—kidney cancer	4.58e-05	0.000665	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—MAPK1—kidney cancer	4.52e-05	0.000656	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—KRAS—kidney cancer	4.45e-05	0.000645	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—MAPK1—kidney cancer	4.36e-05	0.000633	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—MAPK1—kidney cancer	4.36e-05	0.000633	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—KRAS—kidney cancer	4.27e-05	0.00062	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—KRAS—kidney cancer	4.12e-05	0.000598	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—KRAS—kidney cancer	4.12e-05	0.000598	CbGpPWpGaD
